BRAF V600E MUTATION POSITIVE
Clinical trials for BRAF V600E MUTATION POSITIVE explained in plain language.
Never miss a new study
Get alerted when new BRAF V600E MUTATION POSITIVE trials appear
Sign up with your email to follow new studies for BRAF V600E MUTATION POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo shrinks colon tumors before surgery in early trial
Disease control Recruiting nowThis study tests whether giving two targeted drugs (encorafenib and cetuximab) before surgery can shrink tumors in people with a specific genetic mutation (BRAF V600E) in colon or upper rectal cancer. About 30 participants will receive the drug combination for a short time, then …
Matched conditions: BRAF V600E MUTATION POSITIVE
Phase: PHASE2 • Sponsor: Federation Francophone de Cancerologie Digestive • Aim: Disease control
Last updated May 17, 2026 00:42 UTC
-
Researchers track Real-World outcomes for rare colorectal cancer mutation
Knowledge-focused Recruiting nowThis study is gathering medical information and biological samples from 400 adults with a specific genetic mutation (BRAFV600E) in advanced colorectal cancer. The goal is to learn how this cancer is treated in real-world settings and how long patients live. No new treatments are …
Matched conditions: BRAF V600E MUTATION POSITIVE
Phase: NA • Sponsor: UNICANCER • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC